Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 57

1.

Novel cancer immunotherapy agents with survival benefit: recent successes and next steps.

Sharma P, Wagner K, Wolchok JD, Allison JP.

Nat Rev Cancer. 2011 Oct 24;11(11):805-12. doi: 10.1038/nrc3153. Review.

PMID:
22020206
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

A methodological framework to enhance the clinical success of cancer immunotherapy.

Hoos A, Britten CM, Huber C, O'Donnell-Tormey J.

Nat Biotechnol. 2011 Oct 13;29(10):867-70. doi: 10.1038/nbt.2000. No abstract available.

PMID:
21997622
[PubMed - indexed for MEDLINE]
3.

The impact of harmonization on ELISPOT assay performance.

Janetzki S, Britten CM.

Methods Mol Biol. 2012;792:25-36. doi: 10.1007/978-1-61779-325-7_2.

PMID:
21956498
[PubMed - indexed for MEDLINE]
4.

Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab.

Yuan J, Adamow M, Ginsberg BA, Rasalan TS, Ritter E, Gallardo HF, Xu Y, Pogoriler E, Terzulli SL, Kuk D, Panageas KS, Ritter G, Sznol M, Halaban R, Jungbluth AA, Allison JP, Old LJ, Wolchok JD, Gnjatic S.

Proc Natl Acad Sci U S A. 2011 Oct 4;108(40):16723-8. doi: 10.1073/pnas.1110814108. Epub 2011 Sep 20.

PMID:
21933959
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Preculture of PBMCs at high cell density increases sensitivity of T-cell responses, revealing cytokine release by CD28 superagonist TGN1412.

Römer PS, Berr S, Avota E, Na SY, Battaglia M, ten Berge I, Einsele H, Hünig T.

Blood. 2011 Dec 22;118(26):6772-82. doi: 10.1182/blood-2010-12-319780. Epub 2011 Sep 19.

PMID:
21931118
[PubMed - indexed for MEDLINE]
Free Article
6.

Features associated with survival in metastatic melanoma patients treated with patient-specific dendritic cell vaccines.

Dillman RO, Fogel GB, Cornforth AN, Selvan SR, Schiltz PM, DePriest C.

Cancer Biother Radiopharm. 2011 Aug;26(4):407-15. doi: 10.1089/cbr.2011.0973. Epub 2011 Aug 3.

PMID:
21812653
[PubMed - indexed for MEDLINE]
7.

Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers.

Butterfield LH, Palucka AK, Britten CM, Dhodapkar MV, Håkansson L, Janetzki S, Kawakami Y, Kleen TO, Lee PP, Maccalli C, Maecker HT, Maino VC, Maio M, Malyguine A, Masucci G, Pawelec G, Potter DM, Rivoltini L, Salazar LG, Schendel DJ, Slingluff CL Jr, Song W, Stroncek DF, Tahara H, Thurin M, Trinchieri G, van Der Burg SH, Whiteside TL, Wigginton JM, Marincola F, Khleif S, Fox BA, Disis ML.

Clin Cancer Res. 2011 May 15;17(10):3064-76. doi: 10.1158/1078-0432.CCR-10-2234. Epub 2011 May 10. Review.

PMID:
21558394
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Immune parameters affecting the efficacy of chemotherapeutic regimens.

Zitvogel L, Kepp O, Kroemer G.

Nat Rev Clin Oncol. 2011 Mar;8(3):151-60. doi: 10.1038/nrclinonc.2010.223. Review.

PMID:
21364688
[PubMed - indexed for MEDLINE]
9.

Coactivation of AKT and β-catenin in mice rapidly induces formation of lipogenic liver tumors.

Stauffer JK, Scarzello AJ, Andersen JB, De Kluyver RL, Back TC, Weiss JM, Thorgeirsson SS, Wiltrout RH.

Cancer Res. 2011 Apr 1;71(7):2718-27. doi: 10.1158/0008-5472.CAN-10-2705. Epub 2011 Feb 15.

PMID:
21324921
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Cells of origin in cancer.

Visvader JE.

Nature. 2011 Jan 20;469(7330):314-22. doi: 10.1038/nature09781. Review.

PMID:
21248838
[PubMed - indexed for MEDLINE]
11.

TNM staging in colorectal cancer: T is for T cell and M is for memory.

Broussard EK, Disis ML.

J Clin Oncol. 2011 Feb 20;29(6):601-3. doi: 10.1200/JCO.2010.32.9078. Epub 2011 Jan 18. No abstract available.

PMID:
21245434
[PubMed - indexed for MEDLINE]
Free Article
12.

Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction.

Mlecnik B, Tosolini M, Kirilovsky A, Berger A, Bindea G, Meatchi T, Bruneval P, Trajanoski Z, Fridman WH, Pagès F, Galon J.

J Clin Oncol. 2011 Feb 20;29(6):610-8. doi: 10.1200/JCO.2010.30.5425. Epub 2011 Jan 18.

PMID:
21245428
[PubMed - indexed for MEDLINE]
Free Article
13.

A new era: melanoma genetics and therapeutics.

Ko JM, Fisher DE.

J Pathol. 2011 Jan;223(2):241-50. doi: 10.1002/path.2804. Epub 2010 Oct 28. Review.

PMID:
21125678
[PubMed - indexed for MEDLINE]
14.

Genetic instability influences drug response in cancer cells.

Damia G, D'Incalci M.

Curr Drug Targets. 2010 Oct;11(10):1317-24. Review.

PMID:
20840074
[PubMed - indexed for MEDLINE]
15.

Improved endpoints for cancer immunotherapy trials.

Hoos A, Eggermont AM, Janetzki S, Hodi FS, Ibrahim R, Anderson A, Humphrey R, Blumenstein B, Old L, Wolchok J.

J Natl Cancer Inst. 2010 Sep 22;102(18):1388-97. doi: 10.1093/jnci/djq310. Epub 2010 Sep 8. Review.

PMID:
20826737
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Sipuleucel-T immunotherapy for castration-resistant prostate cancer.

Kantoff PW, Higano CS, Shore ND, Berger ER, Small EJ, Penson DF, Redfern CH, Ferrari AC, Dreicer R, Sims RB, Xu Y, Frohlich MW, Schellhammer PF; IMPACT Study Investigators.

N Engl J Med. 2010 Jul 29;363(5):411-22. doi: 10.1056/NEJMoa1001294.

PMID:
20818862
[PubMed - indexed for MEDLINE]
Free Article
17.

Gene signature in melanoma associated with clinical activity: a potential clue to unlock cancer immunotherapy.

Gajewski TF, Louahed J, Brichard VG.

Cancer J. 2010 Jul-Aug;16(4):399-403. doi: 10.1097/PPO.0b013e3181eacbd8. Review.

PMID:
20693853
[PubMed - indexed for MEDLINE]
18.

Dual roles for immunity in gastrointestinal cancers.

Ferrone C, Dranoff G.

J Clin Oncol. 2010 Sep 10;28(26):4045-51. doi: 10.1200/JCO.2010.27.9992. Epub 2010 Jul 19. Review.

PMID:
20644090
[PubMed - indexed for MEDLINE]
19.

New models for cancer research: human cancer stem cell xenografts.

Baiocchi M, Biffoni M, Ricci-Vitiani L, Pilozzi E, De Maria R.

Curr Opin Pharmacol. 2010 Aug;10(4):380-4. doi: 10.1016/j.coph.2010.05.002. Epub 2010 Jun 17. Review.

PMID:
20561817
[PubMed - indexed for MEDLINE]
20.

Improved survival with ipilimumab in patients with metastatic melanoma.

Hodi FS, O'Day SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB, Gonzalez R, Robert C, Schadendorf D, Hassel JC, Akerley W, van den Eertwegh AJ, Lutzky J, Lorigan P, Vaubel JM, Linette GP, Hogg D, Ottensmeier CH, Lebbé C, Peschel C, Quirt I, Clark JI, Wolchok JD, Weber JS, Tian J, Yellin MJ, Nichol GM, Hoos A, Urba WJ.

N Engl J Med. 2010 Aug 19;363(8):711-23. doi: 10.1056/NEJMoa1003466. Epub 2010 Jun 5. Erratum in: N Engl J Med. 2010 Sep 23;363(13):1290.

PMID:
20525992
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk